Attachment A - Adverse Events Reported to Manufacturers of OTC External Analgesic Patch…

Other agency documents in this docket

• FDA-1978-N-0022-0026Letter from the Consumer Healthcare Products Association (CHPA) to FDA/DDM
• FDA-1978-N-0022-0024External Analgesic Drug Products for OTC Human Use; Reopening of the Administrative Record…
• FDA-1978-N-0022-0021Answer from FDA/CDER to Letter from AAC Consulting Group, Inc. to FDA/CDER
• FDA-1978-N-0022-0023Letter from FDA/CDER to Bayer Corporation
• FDA-1978-N-0022-0022Letter from FDA/CDER to Otis Clapp
• FDA-1978-N-0022-0020External Analgesic Drug Products for Over-the-Counter Human Use; Reopening of the…
• FDA-1978-N-0022-0019Antifungal Drug Products for Over-the-Counter Human Use; External Analgesic Drug Products…
• FDA-1978-N-0022-0018Male Genital Desensitizing Drug Products for Over-the-Counter Human Use; Final Monograph
• FDA-1978-N-0022-0017External Analgesic Drug Products for Over-the-Counter Human Use; Tentative Final Monograph
• FDA-1978-N-0022-0016External Analgesic Drug Products for Over-the-Counter Human Use; Amendment to Tentative…